Gilead: Will Immunomedics Be Gilead’s Next Pharmasset?
Gilead Sciences announced on 13th September that it has entered into a definitive agreement to acquire Immunomedics for US$88.00 per share in cash,...
530 Views
Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters
JHBP (CY) Holdings Ltd also known as Genor Biopharma has filed for an IPO on the Hong Kong Stock Exchange to raise about HK$2.48bn (US$320m). The...
566 Views
HSCI Index Rebalance - Stock Connect Flows Coming Up
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....
722 Views
HK IPO Analytics 1H2020: Highlight of Brokers' and Sectors' Performance, and Insti Book Color
As we regularly analyse deal performance, it is time to look at how the HK IPO markets performed during the first half of 2020. In this note, we...
609 Views
Hygeia Healthcare IPO: Trading Debut
Hygeia Healthcare Group (6078 HK) is the largest oncology healthcare group in China as measured by the revenue generated from radiotherapy-related...
474 Views